Federation des caisses Desjardins du Quebec’s Tango Therapeutics TNGX Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$17.1K	Buy	+817	New	+$11.4K	﹤0.01%	2143

Other funds holding TNGX

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

TGI

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's TNGX Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec opened a new position in Tango Therapeutics (TNGX) in Q1 2026: 817 shares worth $17.1K. The stake represents ﹤0.01% of the portfolio and ranks #2143 among its holdings.

194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

Federation des caisses Desjardins du Quebec held 817 shares of Tango Therapeutics worth $17.1K as of Q1 2026.
Tango Therapeutics was a new Federation des caisses Desjardins du Quebec position in Q1 2026.
Tango Therapeutics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #2143 holding.
194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.